欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2954/003
药品名称
Rivastor
活性成分
Rivastigmine 13.3 mg/24h
剂型
Transdermal patch
上市许可持有人
Orion Corporation Orionintie 1 02200 Espoo Finland
参考成员国 - 产品名称
Denmark (DK)
Rivastor
互认成员国 - 产品名称
Sweden (SE)
Finland (FI)
许可日期
2019/11/25
最近更新日期
2025/02/03
药物ATC编码
N06DA03 rivastigmine
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
Common Rivastor SPC_clean
Date of last change:2024/09/06
Final PL
|
EU Rivastor 13_3 mg_24h transdermal patch DCP PIL 160519
Date of last change:2024/09/06
Final Labelling
|
EU Rivastor 13_3mg_24h transdermal patch LABEL 081019
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase